維持性血液透析患者的生存質(zhì)量評(píng)價(jià)及相關(guān)因素分析
本文關(guān)鍵詞: MHD 生存質(zhì)量 KDQOL-SF 出處:《廣西醫(yī)科大學(xué)》2016年碩士論文 論文類(lèi)型:學(xué)位論文
【摘要】:背景:隨著血液透析的廣泛運(yùn)用,維持性血液透析(maintenance hemodialysis MHD)患者的預(yù)期壽命明顯延長(zhǎng),但MHD患者較低生存質(zhì)量的研究屢有報(bào)道。本次研究探討與MI1D患者生存質(zhì)量相關(guān)的因素,為改善和提高M(jìn)HD患者的生存質(zhì)量提供依據(jù)。方法:選取從2016年3月12日到3月20日,在廣西醫(yī)科大學(xué)第一附屬醫(yī)院血液凈化中心治療的維持性血液透析的患者,收集的數(shù)據(jù)包括社會(huì)人口資料,病例資料,血液凈化治療方案和實(shí)驗(yàn)室結(jié)果,使用KDQOL-SF評(píng)估患者的生存質(zhì)量。KDQOL-SF量表其中包括一般健康生存質(zhì)量量表(SF-36)及腎病、透析相關(guān)生存質(zhì)(KDTA)量表。SF-36包括心理相關(guān)生存質(zhì)量(MCS)及生理相關(guān)生存質(zhì)量(PCS)兩個(gè)方面。結(jié)果:KDTA的總分為55.99±8.90。SF-36的總分為47.08±12.03,而PCS總分和MCS總分分別為48.93±16.96和46.67±14.78。KDTA獨(dú)立相關(guān)因素有年齡(B=-0.23、P=0.00)、白蛋白(B=0.55、P=0.00)、對(duì)尿毒癥的認(rèn)識(shí)(B=5.17、P=0.00)、透析病程(B=-0.92、P=0.00)、家庭收入(B=1.30,P=0.00)、教育程度(B=2.26、P=0.00)、透析頻次(Exp(B)=-1.61、p=0.01)。PCS的獨(dú)立相關(guān)因素有年齡(B=-0.54、P=0.00)、性別(B=7.19,P=0.01)、透析病程(B=-0.89、P=-0.00)、超敏C反應(yīng)蛋白(B=-0.38、P=0.04)。MCS的獨(dú)立相關(guān)因素為年齡(B=-0.36、P=-0.00)、性別(B=-8.03、P=-0.00)、是否患糖尿病(Exp(B)=-4.08、p=0.01)、血紅蛋白(Exp(B)=0.959、p=0.037)。結(jié)論: 社會(huì)人口因素和臨床因素都會(huì)影響廣西MHD患者的生存質(zhì)量,社會(huì)人口因素包括性別、年齡、家庭收入、教育水平。臨床因素包括低白蛋白血癥、透析病程、處于炎癥狀態(tài)、對(duì)尿毒癥的認(rèn)識(shí)、透析頻次、血紅蛋白及是否患有糖尿病。對(duì)生存質(zhì)量低的患者需要醫(yī)護(hù)人員更多的關(guān)注,社會(huì)給予更多的支持。其中包括社會(huì)支持、更加完善的醫(yī)療及營(yíng)養(yǎng)支持等,以減少進(jìn)一步的健康并發(fā)癥,提高廣西MHD患者的質(zhì)量。
[Abstract]:Background: with the widespread use of hemodialysis, life expectancy in patients with maintenance hemodialysis maintenance hemodialysis MHD is significantly prolonged. However, the study of low quality of life in patients with MHD has been reported frequently. This study is to explore the factors related to the quality of life of patients with MI1D. Methods: from March 12th 2016 to March 20th. Data collected from maintenance hemodialysis patients treated at the Blood purification Center of the first affiliated Hospital of Guangxi Medical University include socio-demographic data, case data, blood purification treatment programs and laboratory results. KDQOL-SF was used to evaluate the quality of life (QOL) of patients with KDQOL-SF, including SF-36) and nephropathy. Analysis of the KDTA-related quality of Survival scale SF-36 including psychologically related quality of Life (MCSs) and Physiological-Related quality of Life (PCS). Results the total score of KDTA was 55.99 鹵8.90.SF-36 and the total score was 47.08 鹵12.03. The total score of PCS and MCS were 48.93 鹵16.96 and 46.67 鹵14.78 respectively. The course of dialysis was B ~ (-0.92) (P ~ (0.00)), and the course of dialysis was B ~ (-0.92) / P ~ (0.00) (B _ (5.17) P ~ (0.00)). Family income is 1.30%, education level is 2.26%, and dialysis frequency is -1.61. The independent correlation factors of p0. 01 and PCS were: age, age, age, sex, sex, and course of hemodialysis, respectively. The independent correlation factors of P0. 00- 0. 00G, BX-0. 38A, P0. 04N. MCS were: age-0. 36%-0. 36%-0. 00) (P < 0. 05, P < 0. 05, P < 0. 05, P < 0. 05). Male and female patients were diagnosed as having diabetes mellitus (P < 0.01) and hemoglobin (P < 0. 959, P < 0. 959), if they had diabetes mellitus (P < 0. 003), whether they were suffering from diabetes mellitus (P = 0. 009) or not (P = 0. 01). Conclusion: Socio-demographic factors and clinical factors will affect the quality of life of patients with MHD in Guangxi. The socio-demographic factors include gender, age and family income. Educational level. Clinical factors include hypoalbuminemia, course of dialysis, inflammation, knowledge of uremia, frequency of dialysis. Hemoglobin and diabetes mellitus. Patients with low quality of life need more attention from health care workers, more social support, including social support, better medical and nutritional support, and so on. In order to reduce further health complications and improve the quality of patients with MHD in Guangxi.
【學(xué)位授予單位】:廣西醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2016
【分類(lèi)號(hào)】:R692.5
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 方宗君,蔡映云;慢性阻塞性肺疾病患者生存質(zhì)量的研究進(jìn)展[J];現(xiàn)代康復(fù);2000年09期
2 方積乾,萬(wàn)崇華,郝元濤;與健康有關(guān)的生存質(zhì)量的研究概況[J];中國(guó)康復(fù)醫(yī)學(xué)雜志;2000年01期
3 項(xiàng)鳳梅,符林春;生存質(zhì)量與中醫(yī)的關(guān)系及在中醫(yī)中的運(yùn)用[J];安徽中醫(yī)學(xué)院學(xué)報(bào);2004年03期
4 項(xiàng)鳳梅,符林春,王永梅;生存質(zhì)量與中醫(yī)的關(guān)系及在中醫(yī)的運(yùn)用[J];遼寧中醫(yī)雜志;2004年08期
5 張桂芹;黃秀娟;張顯東;;促進(jìn)健康和提高生存質(zhì)量的護(hù)理活動(dòng)[J];黑龍江醫(yī)藥;2005年04期
6 劉加林;鐘濤;梁傳余;王力紅;劉世喜;;生存質(zhì)量量表選擇的策略[J];四川醫(yī)學(xué);2006年07期
7 李建生;李素云;王明航;;慢性阻塞性肺疾病的功能狀態(tài)和健康相關(guān)生存質(zhì)量的變化[J];河南中醫(yī)學(xué)院學(xué)報(bào);2007年01期
8 吳鴻根;黃順榮;吳東波;羅國(guó)強(qiáng);周明;鄧洪強(qiáng);潘云;;生存質(zhì)量在外科領(lǐng)域中的應(yīng)用[J];重慶醫(yī)學(xué);2007年10期
9 駱仲儀;朱銀潮;葉莉霞;周建揚(yáng);;健康教育對(duì)2型糖尿病患者生存質(zhì)量影響的研究[J];中國(guó)健康教育;2007年08期
10 張曉飛;張瑞麗;袁瑋;黃艷;;癌癥患者照顧者生存質(zhì)量的研究現(xiàn)狀[J];護(hù)理實(shí)踐與研究;2009年03期
相關(guān)會(huì)議論文 前10條
1 涂人順;;六字訣對(duì)中老年練功人群生存質(zhì)量影響的研究[A];第四次全國(guó)中西醫(yī)結(jié)合養(yǎng)生學(xué)與康復(fù)醫(yī)學(xué)學(xué)術(shù)研討會(huì)論文集[C];2004年
2 李建生;余學(xué)慶;李力;;慢性阻塞性肺疾病患者生存質(zhì)量及其影響因素分析[A];第七次全國(guó)中西醫(yī)結(jié)合呼吸病學(xué)術(shù)交流大會(huì)論文匯編(二)[C];2004年
3 王彩霞;盧愛(ài)工;;心理干預(yù)對(duì)增殖型糖尿病性視網(wǎng)膜病變患者生存質(zhì)量的影響[A];全國(guó)五官科護(hù)理學(xué)術(shù)交流暨專(zhuān)題講座會(huì)議論文匯編[C];2007年
4 許維娜;范為群;倪玨民;薛冬梅;錢(qián)s,
本文編號(hào):1484852
本文鏈接:http://sikaile.net/yixuelunwen/mjlw/1484852.html